These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32345117)

  • 21. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
    Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
    J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.
    Zhu QN; Wang G; Guo Y; Peng Y; Zhang R; Deng JL; Li ZX; Zhu YS
    Oncotarget; 2017 Nov; 8(54):91990-92003. PubMed ID: 29190892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
    Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
    Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
    Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
    Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612.
    Zhang L; Wang DL; Yu P
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4820-4827. PubMed ID: 30070313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA H19 promotes proliferation of Hodgkin's lymphoma via AKT pathway.
    Wang Y; Wang L; Sui M
    J BUON; 2019; 24(2):763-769. PubMed ID: 31128034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin.
    Han B; Huang J; Han Y; Hao J; Wu X; Song H; Chen X; Shen Q; Dong X; Pang H; Cai L
    Int J Biol Macromol; 2019 Mar; 125():544-556. PubMed ID: 30537505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L; Hu Z; Zhou Z; Zhang H
    Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
    Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
    Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA H19 competitively binds miR-93-5p to regulate STAT3 expression in breast cancer.
    Li JP; Xiang Y; Fan LJ; Yao A; Li H; Liao XH
    J Cell Biochem; 2019 Mar; 120(3):3137-3148. PubMed ID: 30256448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway.
    Wang J; Wang X; Chen T; Jiang L; Yang Q
    Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs.
    Xu S; Zhao C; Jia Z; Wang X; Han Y; Yang Z
    Arch Gynecol Obstet; 2017 Sep; 296(3):543-549. PubMed ID: 28660502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.
    Wu C; Luo J
    Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
    Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
    Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.